Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-040104

Director bought 797 shares at an average $2.04 ($1,628)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2022-06-01 Purchase +38 $2.05 $78 21,439 D
Jones James Director 2022-06-02 Purchase +38 $2.08 $79 21,477 D
Jones James Director 2022-06-03 Purchase +38 $2.09 $79 21,515 D
Jones James Director 2022-06-06 Purchase +40 $2.07 $83 21,555 D
Jones James Director 2022-06-07 Purchase +30 $2.08 $62 21,585 D
Jones James Director 2022-06-08 Purchase +40 $2.12 $85 21,625 D
Jones James Director 2022-06-09 Purchase +40 $2.09 $84 21,665 D
Jones James Director 2022-06-10 Purchase +40 $2.04 $82 21,705 D
Jones James Director 2022-06-13 Purchase +40 $2.01 $80 21,745 D
Jones James Director 2022-06-14 Purchase +40 $2.02 $81 21,785 D
Jones James Director 2022-06-15 Purchase +40 $1.98 $79 21,825 D
Jones James Director 2022-06-16 Purchase +40 $1.95 $78 21,865 D
Jones James Director 2022-06-17 Purchase +40 $1.94 $78 21,905 D
Jones James Director 2022-06-21 Purchase +42 $1.97 $83 21,947 D
Jones James Director 2022-06-22 Purchase +39 $1.99 $78 21,986 D
Jones James Director 2022-06-23 Purchase +42 $2.01 $84 22,028 D
Jones James Director 2022-06-24 Purchase +42 $2.11 $89 22,070 D
Jones James Director 2022-06-27 Purchase +7 $2.06 $14 22,077 D
Jones James Director 2022-06-28 Purchase +37 $2.06 $76 22,114 D
Jones James Director 2022-06-29 Purchase +42 $2.11 $89 22,156 D
Jones James Director 2022-06-30 Purchase +42 $2.08 $87 22,198 D
Open-market purchases · 797 sh · avg $2.04 · $1,628
Loading xslF345X03/doc4.xml…